SG11201604545XA - Methods useful in the synthesis of halichondrin b analogs - Google Patents

Methods useful in the synthesis of halichondrin b analogs

Info

Publication number
SG11201604545XA
SG11201604545XA SG11201604545XA SG11201604545XA SG11201604545XA SG 11201604545X A SG11201604545X A SG 11201604545XA SG 11201604545X A SG11201604545X A SG 11201604545XA SG 11201604545X A SG11201604545X A SG 11201604545XA SG 11201604545X A SG11201604545X A SG 11201604545XA
Authority
SG
Singapore
Prior art keywords
halichondrin
analogs
synthesis
methods useful
useful
Prior art date
Application number
SG11201604545XA
Other languages
English (en)
Inventor
Yongbo Hu
Huiming Zhang
Bryan M Lewis
Hiroyuki Chiba
Yuki Komatsu
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of SG11201604545XA publication Critical patent/SG11201604545XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11201604545XA 2013-12-06 2014-12-05 Methods useful in the synthesis of halichondrin b analogs SG11201604545XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361912714P 2013-12-06 2013-12-06
PCT/US2014/068834 WO2015085193A1 (fr) 2013-12-06 2014-12-05 Procédés utiles pour la synthèse d'analogues d'halichondrine b

Publications (1)

Publication Number Publication Date
SG11201604545XA true SG11201604545XA (en) 2016-07-28

Family

ID=53270478

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201805024YA SG10201805024YA (en) 2013-12-06 2014-12-05 Methods useful in the synthesis of halichondrin b analogs
SG11201604545XA SG11201604545XA (en) 2013-12-06 2014-12-05 Methods useful in the synthesis of halichondrin b analogs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201805024YA SG10201805024YA (en) 2013-12-06 2014-12-05 Methods useful in the synthesis of halichondrin b analogs

Country Status (13)

Country Link
US (4) US9303039B2 (fr)
EP (2) EP3077399B1 (fr)
JP (3) JP6443812B2 (fr)
CN (1) CN105916861B (fr)
BR (1) BR112016012237B1 (fr)
CA (1) CA2931788C (fr)
ES (1) ES2723355T3 (fr)
HU (1) HUE043088T2 (fr)
IL (4) IL245661A0 (fr)
MX (3) MX370611B (fr)
RU (1) RU2676486C1 (fr)
SG (2) SG10201805024YA (fr)
WO (1) WO2015085193A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46965E1 (en) 2004-06-03 2018-07-24 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of Halichondrin B
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
SG189739A1 (en) 2008-04-04 2013-05-31 Eisai R&D Man Co Ltd Halichondrin b analogs
US8203010B2 (en) 2010-01-26 2012-06-19 Eisai R&D Management Co., Ltd. Compounds useful in the synthesis of halichondrin B analogs
US9783549B2 (en) 2013-11-04 2017-10-10 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B
US9303039B2 (en) * 2013-12-06 2016-04-05 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin B analogs
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX2021002629A (es) 2015-05-07 2022-05-13 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
MX2018009794A (es) 2016-02-12 2018-12-17 Eisai R&D Man Co Ltd Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
CN114272389B (zh) 2016-03-02 2023-04-18 卫材研究发展管理有限公司 基于艾日布林的抗体-药物偶联物和使用方法
CN114805322A (zh) 2016-06-30 2022-07-29 卫材R&D管理有限公司 可用于合成软海绵素大环内酯类及其类似物的普林斯反应和中间体
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
PL3606928T3 (pl) 2017-04-05 2023-02-06 President And Fellows Of Harvard College Związek makrocykliczny i jego zastosowania
WO2018217894A1 (fr) * 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Dérivés d'halichondrine marqués au fluor et procédés de synthèse associés
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
BR112020000141A2 (pt) 2017-07-06 2020-07-14 President And Fellows Of Harvard College síntese de halicondrinas
CN109694379B (zh) * 2017-10-24 2020-09-11 江苏恒瑞医药股份有限公司 用于制备艾日布林的中间体及其制备方法
CN117924310A (zh) 2017-11-15 2024-04-26 哈佛大学的校长及成员们 大环化合物及其用途
EP3713565A1 (fr) 2017-11-20 2020-09-30 Basilea Pharmaceutica International AG Associations pharmaceutiques destinées à être utilisées dans le traitement du cancer
CN111868044B (zh) 2018-01-03 2024-07-19 卫材R&D管理有限公司 可用于合成软海绵素大环内酯及其类似物的普林斯反应和化合物
JP2021532102A (ja) * 2018-07-20 2021-11-25 ドクター レディズ ラボラトリーズ リミテッド エリブリンおよびその中間体の調製のための精製プロセス
US20210340156A1 (en) * 2018-10-09 2021-11-04 Dr. Reddy's Laboratories Limited Process for preparation of eribulin and intermediates thereof
WO2020110146A1 (fr) * 2018-11-28 2020-06-04 Natco Pharma Limited Procédé pour la préparation d'éribuline de haute pureté et de son sel de mésylate
US11447499B2 (en) 2019-06-14 2022-09-20 Rk Pharma Inc. Process for the preparation of eribulin mesylate intermediate
WO2022101931A1 (fr) * 2020-11-10 2022-05-19 Natco Pharma Limited Procédé de préparation d'éribuline et de ses intermédiaires
CN113354659B (zh) 2021-06-08 2022-04-08 江苏慧聚药业股份有限公司 甲磺酸艾日布林的合成
CN114380840B (zh) * 2022-01-27 2024-01-26 江苏慧聚药业股份有限公司 艾日布林的合成

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (fr) 1992-09-09 1995-09-01 Hoechst Ag
JP2001500498A (ja) 1996-09-06 2001-01-16 イーライ・リリー・アンド・カンパニー 触媒選択的スルホニル化法
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
WO1999065894A1 (fr) 1998-06-17 1999-12-23 Eisai Co., Ltd. Analogues macrocycliques, leurs procedes d'utilisation et de preparation
CA2822994C (fr) * 2004-06-03 2016-09-27 Eisai R&D Management Co., Ltd. Intermediaires pour la preparation d'analogues d'halichondrine b
USRE46965E1 (en) 2004-06-03 2018-07-24 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of Halichondrin B
US20060045846A1 (en) 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
EP1831697A4 (fr) 2004-12-09 2011-01-26 Eisai R&D Man Co Ltd Criblage de l'isotype tubuline en therapie du cancer faisant appel aux analogues de l'halichondrine b
WO2008010776A1 (fr) 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycine d et ses dérivés et leur utilisation dans le traitement de cancer ou de paludisme ou d'infection microbienne
WO2009014105A1 (fr) 2007-07-20 2009-01-29 Yamada Apiculture Center, Inc. Nouvel acide carboxylique et composition d'antidépresseur contenant cet acide en tant qu'ingrédient actif
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
EP2220094A1 (fr) 2007-11-16 2010-08-25 Eisai R&D Management Co., Ltd. Nouveau produit intermédiaire pour la synthèse de l'analogue de l'halichondrine b et nouvelle réaction de désulfonylation utilisée pour le produit intermédiaire
SG189739A1 (en) 2008-04-04 2013-05-31 Eisai R&D Man Co Ltd Halichondrin b analogs
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
US8203010B2 (en) 2010-01-26 2012-06-19 Eisai R&D Management Co., Ltd. Compounds useful in the synthesis of halichondrin B analogs
EP2354128A1 (fr) 2010-02-10 2011-08-10 Sandoz Ag Procédé pour la préparation de rivaroxaban
WO2012147900A1 (fr) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Procédé en microréacteurs pour synthèse d'analogue d'halichondrine b
WO2013078559A1 (fr) 2011-11-30 2013-06-06 Alphora Research Inc. Procédé de préparation de (3r)-2,4-di-groupe partant-3-méthylbut-1-ène
IN2014MN02106A (fr) 2012-03-30 2015-09-11 Alphora Res Inc
US9850254B2 (en) 2013-07-03 2017-12-26 Sandoz Ag Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing-SO2-(p-tolyl) groups
US9783549B2 (en) 2013-11-04 2017-10-10 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B
US9303039B2 (en) * 2013-12-06 2016-04-05 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin B analogs
MX2021002629A (es) 2015-05-07 2022-05-13 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
MX2018009794A (es) 2016-02-12 2018-12-17 Eisai R&D Man Co Ltd Intermediarios en la sintesis de eribulina y metodos de sintesis relacionados.
CN114805322A (zh) 2016-06-30 2022-07-29 卫材R&D管理有限公司 可用于合成软海绵素大环内酯类及其类似物的普林斯反应和中间体

Also Published As

Publication number Publication date
US20170298078A1 (en) 2017-10-19
SG10201805024YA (en) 2018-07-30
JP2016540752A (ja) 2016-12-28
JP2019031530A (ja) 2019-02-28
JP6905041B2 (ja) 2021-07-21
CA2931788A1 (fr) 2015-06-11
CN105916861A (zh) 2016-08-31
IL273736B (en) 2021-03-25
MX2016006891A (es) 2017-06-12
JP6443812B2 (ja) 2018-12-26
CA2931788C (fr) 2022-05-24
MX370611B (es) 2019-12-18
JP2020059739A (ja) 2020-04-16
HUE043088T2 (hu) 2019-08-28
CN105916861B (zh) 2018-12-14
BR112016012237A2 (fr) 2017-08-08
US9695188B2 (en) 2017-07-04
EP3077399B1 (fr) 2019-02-20
US20190010166A1 (en) 2019-01-10
IL281275B (en) 2021-12-01
IL273736A (en) 2020-05-31
IL245661A0 (en) 2016-06-30
EP3505520A1 (fr) 2019-07-03
US20160176895A1 (en) 2016-06-23
JP6634135B2 (ja) 2020-01-22
BR112016012237B1 (pt) 2023-02-07
ES2723355T3 (es) 2019-08-26
US9303039B2 (en) 2016-04-05
MX2019011926A (es) 2019-11-18
IL265640B (en) 2020-04-30
EP3077399A1 (fr) 2016-10-12
EP3077399A4 (fr) 2017-05-10
RU2676486C1 (ru) 2018-12-29
US20150158881A1 (en) 2015-06-11
WO2015085193A1 (fr) 2015-06-11
IL265640A (en) 2019-05-30
IL281275A (en) 2021-04-29
MX2020004855A (es) 2021-07-08
US10450324B2 (en) 2019-10-22
US10030032B2 (en) 2018-07-24

Similar Documents

Publication Publication Date Title
IL281275A (en) Useful methods in the synthesis of analogues of licondrin B
IL288468B (en) Microcyclization reactions and useful intermediates in the synthesis of helichondrin b analogs
GB201421334D0 (en) Synthesis of aeizeolite
HK1218142A1 (zh) 正交合成測序
EP2986746A4 (fr) Composés et procédés pour isoler de l'or
PL2875736T3 (pl) N-karbamoiloputrescyna do zwiększenia syntezy białka mięśni
HK1220456A1 (zh) -乙酰嗎啡類似物,和其合成方法和用途
PL3055307T3 (pl) Podstawione berbiny i ich synteza
EP2969941A4 (fr) Procédés et dispositifs pour la synthèse de métallofullerènes
HK1220969A1 (zh) 用於合成伊立替康的方法
PT2799426T (pt) Novo processo para a síntese de aminaftona
GB201300324D0 (en) Improvements to letter-plates
HK1216419A1 (zh) 合成方法
TWM476053U (en) Structure of three-dimensional printer
IL244411B (en) Procedure for the synthesis of derivatives of n-benzyl-n-cyclopropyl-1h-pyrazole-4-carboxamide
GB201322704D0 (en) Synthesis
GB201322922D0 (en) Synthesis of Polyoxometalates
SG10201701021XA (en) Method of synthesis
GB201310660D0 (en) Synthesis of nucleosides
GB201320309D0 (en) 360 Project Compass
GB201310302D0 (en) Sequencer
GB201310481D0 (en) Microsensor
GB201310479D0 (en) Microsensor
GB201310836D0 (en) Dercorative keepsake